Abstract
Boron neutron capture therapy (BNCT) is a cancer-selective radiotherapy to treat malignant tumors using a nuclear reaction of boron isotopes in tumor-localizing drug molecules. To evaluate the efficacy of boron drugs for BNCT, it is crucial to measure the distribution of boron drugs in cells. Here, we present the direct imaging of cellular uptake of boron cluster compound by stimulated Raman scattering microscopy. We demonstrate quantitative analysis of spatial distributions of disodium mercaptoundecahydrododecaborate (BSH)-cholesterol in HeLa cells.
Original language | English |
---|---|
Article number | 112004 |
Journal | Applied Physics Express |
Volume | 12 |
Issue number | 11 |
DOIs | |
Publication status | Published - 2019 Nov 1 |
Externally published | Yes |
ASJC Scopus subject areas
- Engineering(all)
- Physics and Astronomy(all)
Access to Document
Other files and links
Fingerprint
Dive into the research topics of 'Imaging of cellular uptake of boron cluster compound by stimulated Raman scattering microscopy'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Applied Physics Express, Vol. 12, No. 11, 112004, 01.11.2019.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Imaging of cellular uptake of boron cluster compound by stimulated Raman scattering microscopy
AU - Asai, Takuya
AU - Liu, Hanqin
AU - Ozeki, Yasuyuki
AU - Sato, Shinichi
AU - Hayashi, Tomohiro
AU - Nakamura, Hiroyuki
N1 - Funding Information: Takuya Asai Hanqin Liu Yasuyuki Ozeki Shinichi Sato Tomohiro Hayashi Hiroyuki Nakamura Takuya Asai Hanqin Liu Yasuyuki Ozeki Shinichi Sato Tomohiro Hayashi Hiroyuki Nakamura Department of Electrical Engineering and Information Systems, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan Laboratory for Chemistry and Life Science, Institute of Innovative Research, Tokyo Institute of Technology, 4259 Nagatsuta-Cho, Midori-ku, Yokohama 226-8503, Japan School of Materials and Chemical Technology, Tokyo Institute of Technology, 4259 Nagatsuta-cho, Midori-ku, Yokohama 226-8502, Japan JST-PRESTO, 4-1-8 Hon-cho, Kawaguchi, Saitama 332-0012, Japan Takuya Asai, Hanqin Liu, Yasuyuki Ozeki, Shinichi Sato, Tomohiro Hayashi and Hiroyuki Nakamura 2019-11-01 2019-10-16 15:06:49 cgi/release: Article released bin/incoming: New from .zip Ministry of Education, Culture, Sports, Science and Technology https://doi.org/10.13039/501100001700 15KK0184 17H02202 17K20095 18H045420 18K18847 Core Research for Evolutional Science and Technology https://doi.org/10.13039/501100003382 JPMJCR1872 yes Boron neutron capture therapy (BNCT) is a cancer-selective radiotherapy to treat malignant tumors using a nuclear reaction of boron isotopes in tumor-localizing drug molecules. To evaluate the efficacy of boron drugs for BNCT, it is crucial to measure the distribution of boron drugs in cells. Here, we present the direct imaging of cellular uptake of boron cluster compound by stimulated Raman scattering microscopy. We demonstrate quantitative analysis of spatial distributions of disodium mercaptoundecahydrododecaborate (BSH)-cholesterol in HeLa cells. � 2019 The Japan Society of Applied Physics [1] Barth R. F., Coderre J. A., Vicente M. G. H. and Blue T. E. 2005 Clin. Cancer Res. 11 3987 10.1158/1078-0432.CCR-05-0035 Barth R. F., Coderre J. A., Vicente M. G. H. and Blue T. E. Clin. Cancer Res. 1078-0432 11 2005 3987 [2] Nakamura H. 2013 Future Med. Chem. 5 715 10.4155/fmc.13.48 Nakamura H. Future Med. Chem. 5 2013 715 [3] Moss R. L. 2014 Appl. Radiat. Isot. 88 2 10.1016/j.apradiso.2013.11.109 Moss R. L. Appl. Radiat. Isot. 0883-2889 88 2014 2 [4] Aihara T., Morita N., Kamatani N., Kumada H., Ono K., Hiratsuka J. and Harada T. 2014 Appl. Radiat. Isotopes 88 12 10.1016/j.apradiso.2014.04.007 Aihara T., Morita N., Kamatani N., Kumada H., Ono K., Hiratsuka J. and Harada T. Appl. Radiat. Isotopes 0969-8043 88 2014 12 [5] Soloway A. H., Hatanaka H. and Davis M. A. 1967 J. Med. Chem. 10 714 10.1021/jm00316a042 Soloway A. H., Hatanaka H. and Davis M. A. J. Med. Chem. 0022-2623 10 1967 714 [6] Hatanaka H. 1975 J. Neurol. 209 81 10.1007/BF00314601 Hatanaka H. J. Neurol. 0340-5354 209 1975 81 [7] Hatanaka H. and Nakagawa Y. 1994 Int. J. Radiat. Oncol. Biol. Phys. 28 1061 10.1016/0360-3016(94)90479-0 Hatanaka H. and Nakagawa Y. Int. J. Radiat. Oncol. Biol. Phys. 0360-3016 28 1994 1061 [8] Snyder H. R., Reedy A. J. and Lennarz W. J. 1958 J. Am. Chem. Soc. 80 835 10.1021/ja01537a021 Snyder H. R., Reedy A. J. and Lennarz W. J. J. Am. Chem. Soc. 80 1958 835 [9] Mishima Y., Honda C., Ichihashi M., Obara H., Hiratsuka J., Fukuda H., Karashima H., Kobayashi T., Kanda K. and Yoshino K. 1989 Lancet 2 388 10.1016/S0140-6736(89)90567-9 Mishima Y., Honda C., Ichihashi M., Obara H., Hiratsuka J., Fukuda H., Karashima H., Kobayashi T., Kanda K. and Yoshino K. Lancet 2 1989 388 [10] Kahl S. B. and Koo M.-S. 1990 J. Chem. Soc., Chem. Commun. 1769 10.1039/C39900001769 Kahl S. B. and Koo M.-S. J. Chem. Soc., Chem. Commun. 0022-4936 1990 1769 [11] Ratajski M., Osterloh J. and Gabel D. 2006 Anticancer Agents Med. Chem. 6 159 10.2174/187152006776119126 Ratajski M., Osterloh J. and Gabel D. Anticancer Agents Med. Chem. 6 2006 159 [12] Matsumura A. et al 1999 Cancer Lett. 141 203 10.1016/S0304-3835(99)00105-6 Matsumura A. et al Cancer Lett. 141 1999 203 [13] El-Zaria M. E., Ban H. S. and Nakamura H. 2010 Chemistry 16 1543 10.1002/chem.200901532 El-Zaria M. E., Ban H. S. and Nakamura H. Chemistry 16 2010 1543 [14] Kabalka G. W., Wu Z. Z., Yao M. L. and Natarajan N. 2004 Appl. Radiat. Isot. 61 1111 10.1016/j.apradiso.2004.05.012 Kabalka G. W., Wu Z. Z., Yao M. L. and Natarajan N. Appl. Radiat. Isot. 0883-2889 61 2004 1111 [15] Hattori Y., Kusaka S., Mukumoto M., Uehara K., Asano T., Suzuki M., Masunaga S.-I., Ono K., Tanimori S. and Kirihata M. 2012 J. Med. Chem. 55 6980 10.1021/jm300749q Hattori Y., Kusaka S., Mukumoto M., Uehara K., Asano T., Suzuki M., Masunaga S.-I., Ono K., Tanimori S. and Kirihata M. J. Med. Chem. 55 2012 6980 [16] Wu G., Barth R. F., Yang W., Chatterjee M., Tjarks W., Ciesielski M. J. and Fenstermaker R. A. 2004 Bioconjugate Chem. 15 185 10.1021/bc0341674 Wu G., Barth R. F., Yang W., Chatterjee M., Tjarks W., Ciesielski M. J. and Fenstermaker R. A. Bioconjugate Chem. 1043-1802 15 2004 185 [17] Yanagië H., Tomita T., Kobayashi H., Fujii Y., Nonaka Y., Saegusa Y., Hasumi K., Eriguchi M., Kobayashi T. and Ono K. 1997 Br. J. Cancer 75 660 10.1038/bjc.1997.118 Yanagië H., Tomita T., Kobayashi H., Fujii Y., Nonaka Y., Saegusa Y., Hasumi K., Eriguchi M., Kobayashi T. and Ono K. Br. J. Cancer 75 1997 660 [18] Shelly K., Feakes D. A., Hawthorne M. F., Schmidt P. G., Krisch T. A. and Bauer W. F. 1992 Proc. Natl. Acad. Sci. U.S.A. 89 9039 10.1073/pnas.89.19.9039 Shelly K., Feakes D. A., Hawthorne M. F., Schmidt P. G., Krisch T. A. and Bauer W. F. Proc. Natl. Acad. Sci. U.S.A. 0027-8424 89 1992 9039 [19] Maruyama K., Ishida O., Kasaoka S., Takizawa T., Utoguchi N., Shinohara A., Chiba M., Kobayashi H., Eriguchi M. and Yanagie H. 2004 J. Control. Release 98 195 10.1016/j.jconrel.2004.04.018 Maruyama K., Ishida O., Kasaoka S., Takizawa T., Utoguchi N., Shinohara A., Chiba M., Kobayashi H., Eriguchi M. and Yanagie H. J. Control. Release 0168-3659 98 2004 195 [20] Nakamura H., Miyajima Y., Takei T., Kasaoka S. and Maruyama K. 2004 Chem. Commun. 1910 10.1039/B406141A Nakamura H., Miyajima Y., Takei T., Kasaoka S. and Maruyama K. Chem. Commun. 2004 1910 [21] Ueno M., Ban H. S., Nakai K., Inomata R., Kaneda Y., Matsumura A. and Nakamura H. 2010 Bioorg. Med. Chem. 18 3059 10.1016/j.bmc.2010.03.050 Ueno M., Ban H. S., Nakai K., Inomata R., Kaneda Y., Matsumura A. and Nakamura H. Bioorg. Med. Chem. 0968-0896 18 2010 3059 [22] Koganei H. et al 2013 Bioconjugate Chem. 24 124 10.1021/bc300527n Koganei H. et al Bioconjugate Chem. 1043-1802 24 2013 124 [23] Tachikawa S., Miyoshi T., Koganei H., El-Zaria M. E., Viñas C., Suzuki M., Ono K. and Nakamura H. 2014 Chem. Commun. 50 12325 10.1039/C4CC04344H Tachikawa S., Miyoshi T., Koganei H., El-Zaria M. E., Viñas C., Suzuki M., Ono K. and Nakamura H. Chem. Commun. 50 2014 12325 [24] Iguchi Y., Michiue H., Kitamatsu M., Hayashi Y., Takenaka F., Nishiki T.-I. and Matsui H. 2015 Biomaterials 56 10 10.1016/j.biomaterials.2015.03.061 Iguchi Y., Michiue H., Kitamatsu M., Hayashi Y., Takenaka F., Nishiki T.-I. and Matsui H. Biomaterials 0142-9612 56 2015 10 [25] Kikuchi S., Kanoh D., Sato S., Sakurai Y., Suzuki M. and Nakamura H. 2016 J. Control. Release 237 160 10.1016/j.jconrel.2016.07.017 Kikuchi S., Kanoh D., Sato S., Sakurai Y., Suzuki M. and Nakamura H. J. Control. Release 0168-3659 237 2016 160 [26] Zhang T. et al 2019 Colloid. Surface. B 182 110397 10.1016/j.colsurfb.2019.110397 Zhang T. et al Colloid. Surface. B 182 110397 2019 [27] Imahori Y., Ueda S., Ohmori Y., Kusuki T., Ono K., Fujii R. and Ido T. 1998 J. Nucl. Med. 39 325 Imahori Y., Ueda S., Ohmori Y., Kusuki T., Ono K., Fujii R. and Ido T. J. Nucl. Med. 39 1998 325 [28] Ishiwata K. 2019 Ann. Nucl. Med. 33 223 10.1007/s12149-019-01347-8 Ishiwata K. Ann. Nucl. Med. 0914-7187 33 2019 223 [29] Tanaka H., Sakurai Y., Suzuki M., Masunaga S.-I., Takamiya K., Maruhashi A. and Ono K. 2014 J. Radiat. Res. 55 373 10.1093/jrr/rrt110 Tanaka H., Sakurai Y., Suzuki M., Masunaga S.-I., Takamiya K., Maruhashi A. and Ono K. J. Radiat. Res. 0449-3060 55 2014 373 [30] Mochizuki M., Sato S., Asatyas S., Leśnikowski Z. J., Hayashi T. and Nakamura H. 2019 RSC Adv. 9 23973 10.1039/C9RA04228H Mochizuki M., Sato S., Asatyas S., Leśnikowski Z. J., Hayashi T. and Nakamura H. RSC Adv. 9 2019 23973 [31] Cheng J. X. and Xie X. S. 2015 Science 350 aaa8870 10.1126/science.aaa8870 Cheng J. X. and Xie X. S. Science 350 aaa8870 2015 [32] Ozeki Y., Umemura W., Otsuka Y., Satoh S., Hashimoto H., Sumimura K., Nishizawa N., Fukui K. and Itoh K. 2012 Nature Photon 6 845 10.1038/nphoton.2012.263 Ozeki Y., Umemura W., Otsuka Y., Satoh S., Hashimoto H., Sumimura K., Nishizawa N., Fukui K. and Itoh K. Nature Photon 6 2012 845 [33] Ozeki Y., Asai T., Shou J. and Yoshimi H. 2018 IEEE J. Sel. Top. Quantum Electron. 25 7100211 Ozeki Y., Asai T., Shou J. and Yoshimi H. IEEE J. Sel. Top. Quantum Electron. 1077-260X 25 7100211 2018 [34] Fu D., Zhou J., Zhu W. S., Manley P. W., Wang Y. K., Hood T., Wylie A. and Xie X. S. 2014 Nat. Chem. 6 614 10.1038/nchem.1961 Fu D., Zhou J., Zhu W. S., Manley P. W., Wang Y. K., Hood T., Wylie A. and Xie X. S. Nat. Chem. 6 2014 614 [35] Wakisaka Y. et al 2016 Nat. Microbiol. 1 16124 10.1038/nmicrobiol.2016.124 Wakisaka Y. et al Nat. Microbiol. 1 2016 16124 [36] Fu D., Yang W. and Xie X. S. 2017 J. Am. Chem. Soc. 139 583 10.1021/jacs.6b10727 Fu D., Yang W. and Xie X. S. J. Am. Chem. Soc. 139 2017 583 [37] He R., Xu Y., Zhang L., Ma S., Wang X., Ye D. and Ji M. 2017 Optica 4 44 10.1364/OPTICA.4.000044 He R., Xu Y., Zhang L., Ma S., Wang X., Ye D. and Ji M. Optica 4 2017 44 [38] Ota N., Yonamine Y., Asai T., Yalikun Y., Ito T., Ozeki Y., Hoshino Y. and Tanaka Y. 2019 Anal. Chem. 91 9631 10.1021/acs.analchem.9b01007 Ota N., Yonamine Y., Asai T., Yalikun Y., Ito T., Ozeki Y., Hoshino Y. and Tanaka Y. Anal. Chem. 91 2019 9631 [39] Suzuki Y. et al 2019 Proc. Natl. Acad. Sci. U.S.A. 116 15842 10.1073/pnas.1902322116 Suzuki Y. et al Proc. Natl. Acad. Sci. U.S.A. 0027-8424 116 2019 15842 [40] Egawa M., Iwanaga S., Hosoi J., Goto M., Yamanishi H., Miyai M., Katagiri C., Tokunaga K., Asai T. and Ozeki Y. 2019 Sci. Rep. 9 12601 10.1038/s41598-019-49035-x Egawa M., Iwanaga S., Hosoi J., Goto M., Yamanishi H., Miyai M., Katagiri C., Tokunaga K., Asai T. and Ozeki Y. Sci. Rep. 9 2019 12601 [41] Zhang D., Slipchenko M. N. and Cheng J.-X. 2011 J. Phys. Chem. Lett. 2 1248 10.1021/jz200516n Zhang D., Slipchenko M. N. and Cheng J.-X. J. Phys. Chem. Lett. 2 2011 1248 [42] Liao C.-S., Choi J. H., Zhang D., Chan S. H. and Cheng J.-X. 2015 J. Phys. Chem. C 119 19397 10.1021/acs.jpcc.5b06980 Liao C.-S., Choi J. H., Zhang D., Chan S. H. and Cheng J.-X. J. Phys. Chem. C 1932-7447 119 2015 19397 Publisher Copyright: © 2019 The Japan Society of Applied Physics.
PY - 2019/11/1
Y1 - 2019/11/1
N2 - Boron neutron capture therapy (BNCT) is a cancer-selective radiotherapy to treat malignant tumors using a nuclear reaction of boron isotopes in tumor-localizing drug molecules. To evaluate the efficacy of boron drugs for BNCT, it is crucial to measure the distribution of boron drugs in cells. Here, we present the direct imaging of cellular uptake of boron cluster compound by stimulated Raman scattering microscopy. We demonstrate quantitative analysis of spatial distributions of disodium mercaptoundecahydrododecaborate (BSH)-cholesterol in HeLa cells.
AB - Boron neutron capture therapy (BNCT) is a cancer-selective radiotherapy to treat malignant tumors using a nuclear reaction of boron isotopes in tumor-localizing drug molecules. To evaluate the efficacy of boron drugs for BNCT, it is crucial to measure the distribution of boron drugs in cells. Here, we present the direct imaging of cellular uptake of boron cluster compound by stimulated Raman scattering microscopy. We demonstrate quantitative analysis of spatial distributions of disodium mercaptoundecahydrododecaborate (BSH)-cholesterol in HeLa cells.
UR - http://www.scopus.com/inward/record.url?scp=85075982520&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85075982520&partnerID=8YFLogxK
U2 - 10.7567/1882-0786/ab4a5d
DO - 10.7567/1882-0786/ab4a5d
M3 - Article
AN - SCOPUS:85075982520
SN - 1882-0778
VL - 12
JO - Applied Physics Express
JF - Applied Physics Express
IS - 11
M1 - 112004
ER -